
Magipics has continued producing animations and illustrations for Clarity Pharmaceuticals. The most recent one describes SAR-bisPSMA, a next generation, highly targeted theranostic radiopharmaceutical. It has increased specificity and in-vivo stability, and is being developed for diagnosing, staging and subsequently treating cancers that express Prostate Specific Membrane Antigen (PSMA).
Prostate cancer is the second most common cancer in men and the 5th leading cause of death in men worldwide. Early detection and better treatment options for prostate cancer are therefore of vital importance.
The animation and illustrations can be viewed on the Clarity Pharmaceuticals website.





